TOCA News and Press, Tocagen From 05/07/19

Tocagen (NASDAQ: TOCA ): Q1 GAAP EPS of -$0.74 beats by $0.03 . Cash and equivalents of $80.1M. Press Release More news on: Tocagen Inc., Earnings news and commentary, Healthcare stocks news, ,

SAN DIEGO , May 7, 2019 /PRNewswire/ --  Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today reported financial results and business highlights for the first quarter ended March 31, 2019 . "We had a strong start to the year with exce...

SAN DIEGO , April 30, 2019 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced it will report its first quarter 2019 financial results and business progress on Tuesday, May 7, 2019 , after the close of the U.S. financial...

Gainers: LXRX   +12.2% . MGI   +3.6% . OMF   +2.7% . LAZ   +1.8% . AMC   +1.6% . More news on: Lexicon Pharmaceuticals, Inc., MoneyGram International, Inc., OneMain Holdings, Inc., Stocks on the move, Read more ...

Aurora Cannabis (NYSE: ACB ) initiated with Buy rating and C$16.50 (35% upside) price target at Desjardins. Shares up  1%  premarket on the heels of its license deal with EnWave. More news on: Aurora Cannabis Inc., Gilead Sciences, Inc., Tocagen Inc., Healthcare stocks news, Stoc...

The most common of all follies is to believe passionately in the palpably not true. It is the chief occupation of mankind ." - H. L. Mencken Today, we take a look at a small gene therapy concern that just came public a couple of years ago and has an advancing pipeline. Company Overview...

SAN DIEGO , April 15, 2019 /PRNewswire/ --   Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced the appointment of Fairooz Kabbinavar, M.D., FACP, as senior vice president, clinical development. Dr. Kabbinavar will oversee the adva...

Noteworthy events during the week of April 7 - 13 for healthcare investors. More news on: Cigna Corporation, CVS Health Corporation, Humana Inc., Healthcare stocks news, , Read more ...

SAN DIEGO , March 27, 2019 /PRNewswire/ --  Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced three presentations of updated clinical and preclinical data at the American Association for Cancer Research (AACR) Annual Meeting 2019 ...

Sorrento Therapeutics ( SRNE ) was expected to commercialize ZTlido in Q4 2018. In 2019, it should help increase the revenue line and the stock price. In addition, the company should be conducting a Phase 2 trial of anti-CEA CAR-T cell therapy in 2019. On top of it, the most recent merger sign...